Pathological effects of SARS-CoV-2 on hematological and immunological cells: Alterations in count, morphology, and

Ehsan Ahmadi1, Zahra Bagherpour2, Elmira Zarei2

  • 1Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Insights

COVID-19, caused by SARS-CoV-2, significantly alters immune and blood cells. Understanding these hematological and immunological changes is crucial for effective COVID-19 patient management and treatment strategies.

Area of Science:

  • Immunology
  • Hematology
  • Virology

Background:

  • Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) caused a global pandemic, leading to millions of infections and deaths.
  • The virus profoundly impacts the host's immunological and hematological systems, contributing to disease pathology and clinical symptoms.

Purpose of the Study:

  • To review the effects of COVID-19 on the count, function, and morphology of immune and blood cells.
  • To elucidate the role of these cellular alterations in the pathophysiology of COVID-19.

Main Methods:

  • This review synthesizes existing research on COVID-19's impact on hematological and immunological parameters.
  • Literature search was conducted using relevant keywords related to COVID-19, immune cells, blood cells, and pathophysiology.

Main Results:

  • COVID-19 infection is associated with significant changes in white blood cell counts, including lymphopenia and neutrophilia.
  • Alterations in red blood cell morphology and function, as well as platelet count and activation, have been observed.
  • Immune cell functions, such as T-cell and B-cell responses, are impaired during SARS-CoV-2 infection.

Conclusions:

  • The hematological and immunological alterations observed in COVID-19 patients are critical to understanding disease progression.
  • Further research into these cellular changes can guide the development of targeted therapies and improve patient outcomes.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.2K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.3K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
1.8K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.8K